SCHEMBL19088829

SCHEMBL19088829

C=C(C)NCCc1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESRRG P62508 1/20 0.50
▸ GFER P55789 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.46
▸ F13A1 P00488 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MAOB P27338 4/20 0.42
▸ MAOA P21397 2/20 0.42
▸ IDO1 P14902 1/20 0.41
▸ HIF1A Q16665 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ PPID Q08752 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA6 P23280 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ CA5B Q9Y2D0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15359146 0.84 ESRRG (0.54) ESRRGGFERKDM4EF13A1SMN1; SMN2
SCHEMBL25683773 0.82 NPC1 (0.53) KDM4EF13A1SMN1; SMN2LMNACA12
SCHEMBL13930810 0.82 KDM4E (0.47) KDM4EF13A1SMN1; SMN2HIF1ALMNA
SCHEMBL2715966 0.81 KDM4E (0.70) ESRRGGFERKDM4EF13A1SMN1; SMN2
SCHEMBL6307134 0.80 NPC1 (0.59) SMN1; SMN2IDO1LMNACA12CA1
Water SCHEMBL17767324 0.78 NPC1 (0.57) SMN1; SMN2IDO1LMNACA12CA1
SCHEMBL26709576 0.76 ESRRG (0.57) ESRRGGFERKDM4EF13A1SMN1; SMN2
SCHEMBL15940162 0.76 ESRRG (0.57) ESRRGGFERKDM4EF13A1SMN1; SMN2
SCHEMBL6679010 0.74 ST14 (0.50) ESRRGGFERKDM4EF13A1MAOB
SCHEMBL625333 0.74 ESRRG (0.55) ESRRGGFERKDM4EF13A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041842-B1 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS KAROS PHARMACEUTICALS INC (US) 2019-10-23 — — EP disclosed
WO-2017114864-A1 METHOD FOR PREPARING ACYLATED CROSSLINKED GLYCOSAMINOGLYCANS GALDERMA S.A. (CH) 2017-07-06 — — WO disclosed
Send feedback